Viewing Study NCT04701203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-02-19 @ 7:08 AM
Study NCT ID: NCT04701203
Status: COMPLETED
Last Update Posted: 2025-03-18
First Post: 2021-01-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism
Sponsor: Ascendis Pharma Bone Diseases A/S
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypoparathyroidism View
None Endocrine System Diseases View
None Parathyroid Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypoparathyroidism View
None Parathyroid Hormone View
None TransCon PTH View
None PTH(1-34) View
None Prodrug View
None Sustained Release View
None Parathyroid Hormone Replacement Therapy View
None Palopegteriparatide View